Karl W Vosatka
Overview
Explore the profile of Karl W Vosatka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
56
Followers
0
Related Specialties
Related Specialties
Co-Authors
Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vosatka K, Lavenus S, Logue J
PLoS One
. 2022 Apr;
17(4):e0267740.
PMID: 35486637
When confined, cells have recently been shown to undergo a phenotypic switch to what has been termed, fast amoeboid (leader bleb-based) migration. However, as this is a nascent area of...
2.
Lavenus S, Vosatka K, Caruso A, Ullo M, Khan A, Logue J
J Cell Sci
. 2022 Apr;
135(8).
PMID: 35362531
When metastasizing, tumor cells must traverse environments with diverse physicochemical properties. Recently, the cell nucleus has emerged as a major regulator of the transition from mesenchymal to fast amoeboid (leader...
3.
Gabbireddy S, Vosatka K, Chung A, Logue J
Sci Rep
. 2021 Sep;
11(1):17804.
PMID: 34493759
For metastasis to occur, cancer cells must traverse a range of tissue environments. In part, this is accomplished by cells adjusting their migration mode to one that is best suited...
4.
Lavenus S, Tudor S, Ullo M, Vosatka K, Logue J
J Biol Chem
. 2020 Apr;
295(19):6700-6709.
PMID: 32234762
Tumor cells can spread to distant sites through their ability to switch between mesenchymal and amoeboid (bleb-based) migration. Because of this difference, inhibitors of metastasis must account for each migration...